The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells
Open accessAbstract
Thrombospondin-1 (TSP-1) is a naturally occurring inhibitor of angiogenesis that is able to make normal endothelial cells unresponsive to a wide variety of inducers. Here we use both native TSP-1 and small antiangiogenic peptides derived from it to show that this inhibition is mediated by CD36, a transmembrane glycoprotein found on microvascular endothelial cells. Both IgG antibodies against CD36 and glutathione-S-transferase–CD36 fusion proteins that contain the TSP-1 binding site blocked the ability of intact TSP-1 and its active peptides to inhibit the migration of cultured microvascular endothelial cells. In addition, antiangiogenic TSP-1 peptides inhibited the binding of native TSP-1 to solid phase CD36 and its fusion proteins, as well as to CD36-expressing cells. Additional molecules known to bind CD36, including the IgM anti-CD36 antibody SM∅, oxidized (but not unoxidized) low density lipoprotein, and human collagen 1, mimicked TSP-1 by inhibiting the migration of human microvascular endothelial cells. Transfection of CD36-deficient human umbilical vein endothelial cells with a CD36 expression plasmid caused them to become sensitive to TSP-1 inhibition of their migration and tube formation. This work demonstrates that endothelial CD36, previously thought to be involved only in adhesion and scavenging activities, may be essential for the inhibition of angiogenesis by thrombospondin-1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nagata, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81874-7 · Cited by 4,938
Folkman, J., & Klagsbrun, M. (1987) · Science · doi:10.1126/science.2432664 · Cited by 3,491
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Clinical Applications of Research on Angiogenesis
Folkman, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512283332608 · Cited by 2,264
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,438
Self-citationCD36 is a receptor for oxidized low density lipoprotein
Endemann, G., Stanton, L. W., Madden, K. S., Bryant, C. M., White, R. T., & Protter, A. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50272-1 · Cited by 1,281
Good, D. J., Polverini, P. J., Rastinejad, F., Le Beau, M. M., Lemons, R. S., Frazier, W. A., & Bouck, N. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6624 · Cited by 1,054
Self-citationKlagsbrun, M., & D'Amore, P. A. (1991) · Annual Review of Physiology · doi:10.1146/annurev.ph.53.030191.001245 · Cited by 957
Savill, J., Hogg, N., Ren, Y., & Haslett, C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116019 · Cited by 813
Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1.
Bornstein, P. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.3.503 · Cited by 666
Cary, L. A., Chang, J. F., & Guan, J.-L. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.7.1787 · Cited by 596
Koch, A. E., Harlow, L. A., Haines, G. K., Amento, E. P., Unemori, E. N., Wong, W. L., Pope, R. M., & Ferrara, N. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.8.4149 · Cited by 575
Tolsma, S., Volpert, O., Good, D., Frazier, W., Polverini, P., & Bouck, N. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.2.497 · Cited by 573
Self-citationThe Class B Scavenger Receptors SR-BI and CD36 Are Receptors for Anionic Phospholipids
Rigotti, A., Acton, S. L., & Krieger, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.16221 · Cited by 557
Greenwalt, D., Lipsky, R., Ockenhouse, C., Ikeda, H., Tandon, N., & Jamieson, G. (1992) · Blood · doi:10.1182/blood.v80.5.1105.1105 · Cited by 518
Gilmore, A. P., & Romer, L. H. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.8.1209 · Cited by 513
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60862-3 · Cited by 510
Isolation of the thrombospondin membrane receptor.
Asch, A. S., Barnwell, J., Silverstein, R. L., & Nachman, R. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112918 · Cited by 508
Self-citationIdentification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion
Tandon, N. N., Kralisz, U., & Jamieson, G. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83273-2 · Cited by 489
CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes
Oquendo, P., Hundt, E., Lawler, J., & Seed, B. (1989) · Cell · doi:10.1016/0092-8674(89)90406-6 · Cited by 471
Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene
Rastinejad, F., Polverini, P. J., & Bouck, N. P. (1989) · Cell · doi:10.1016/0092-8674(89)90238-9 · Cited by 463
Self-citationTaraboletti, G., Roberts, D., Liotta, L. A., & Giavazzi, R. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.765 · Cited by 411
Huang, M. M., Bolen, J. B., Barnwell, J. W., Shattil, S. J., & Brugge, J. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7844 · Cited by 406
Integrin-associated Protein Is a Receptor for the C-terminal Domain of Thrombospondin
Gao, A.-G., Lindberg, F. P., Finn, M. B., Blystone, S. D., Brown, E. J., & Frazier, W. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.21 · Cited by 402
Self-citationBaruch, D. I., Gormely, J. A., Ma, C., Howard, R. J., & Pasloske, B. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3497 · Cited by 399
CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis.
Ren, Y., Silverstein, R. L., Allen, J., & Savill, J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1857 · Cited by 389
Self-citationWeinstat‐Saslow, D., Zabrenetzky, V. S., VanHoutte, K., Frazier, W. A., Roberts, D. D., & Steeg, P. S. (1994) · PubMed · Cited by 348
Self-citationNozaki, S., Kashiwagi, H., Yamashita, S., Nakagawa, T., Kostner, B., Tomiyama, Y., Nakata, A., Ishigami, M., Miyagawa, J., & Kameda-Takemura, K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118231 · Cited by 340
Swerlick, R. A., Lee, K. H., Wick, T. M., & Lawley, T. J. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.1.78 · Cited by 282
Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro.
Iruela-Arispe, M. L., Bornstein, P., & Sage, H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.5026 · Cited by 269
Nicholson, A. C., Frieda, S., Pearce, A., & Silverstein, R. L. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.2.269 · Cited by 268
Self-citationStern, M., Savill, J., & Haslett, C. (1996) · Europe PMC (PubMed Central) · Cited by 239
CD36 participates in the phagocytosis of rod outer segments by retinal pigment epithelium
Ryeom, S. W., Sparrow, J. R., & Silverstein, R. L. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.2.387 · Cited by 230
Self-citationAsch, A. S., Liu, I., Briccetti, F. M., Barnwell, J. W., Kwakye-Berko, F., Dokun, A., Goldberger, J., & Pernambuco, M. (1993) · Science · doi:10.1126/science.7504322 · Cited by 220
Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity
Volpert, O. V., Dameron, K. M., & Bouck, N. (1997) · Oncogene · doi:10.1038/sj.onc.1200977 · Cited by 210
Self-citationThrombospondin sequence motif (CSVTCG) is responsible for CD36 binding
Asch, A. S., Silbiger, S., Heimer, E., & Nachman, R. L. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91860-s · Cited by 203
Inhibition of Angiogenesis by Thrombospondin-2
Volpert, O. V., Tolsma, S. S., Pellerin, S., Feige, J. J., Chen, H., Mosher, D. F., & Bouck, N. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2780 · Cited by 201
Self-citationGately, S. T., Twardowski, P., Stack, M. S., Patrick, M., Boggio, L. N., Cundiff, D. L., Schnaper, H. W., Madison, L. D., Volpert, O. V., Bouck, N., et al. (1996) · PubMed · Cited by 197
Self-citationVascular endothelial growth factor
Ferrara, N. (1993) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(93)90046-9 · Cited by 188
Petzelbauer, P., Bender, J. R., Wilson, J., & Pober, J. S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.9.5062 · Cited by 187
Mikhailenko, I., Kounnas, M. Z., & Strickland, D. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9543 · Cited by 176
Frazier, W. A. (1991) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(91)90052-z · Cited by 173
Self-citationThe Emerging Field of Receptor-Mediated Inhibitory Signaling: SHP or SHIP?
Scharenberg, A. M., & Kinet, J.-P. (1996) · Cell · doi:10.1016/s0092-8674(00)81790-0 · Cited by 171
Specific inhibition of endothelial cell proliferation by thrombospondin
Bagavandoss, P., & Wilks, J. W. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)92171-u · Cited by 170
Vogel, T., Guo, N., Krutzsch, H. C., Blake, D. A., Hartman, J. R., Mendelovitz, S., Panet, A., & Roberts, D. D. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240530109 · Cited by 153
Ryeom, S. W., Silverstein, R. L., Scotto, A. W., & Sparrow, J. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20536 · Cited by 151
Self-citationGodyna, S., Liau, G., Popa, I., Stefansson, S., & Argraves, W. S. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.129.5.1403 · Cited by 140
Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells
Canfield, A. E., & Schor, A. M. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.2.797 · Cited by 132
Ockenhouse, C. F., Magowan, C., & Chulay, J. D. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114188 · Cited by 130
The functions of thrombospondin and its involvement in physiology and pathophysiology
Lahav, J. (1993) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(93)90146-r · Cited by 123
Guo, N., Krutzsch, H. C., Nègre, E., Zabrenetzky, V. S., & Roberts, D. D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41781-4 · Cited by 117
Downregulation of Endothelial Cell Thrombospondin 1 Enhances in vitro Angiogenesis
DiPietro, L. A., Nebgen, D. R., & Polverini, P. J. (1994) · Journal of Vascular Research · doi:10.1159/000319585 · Cited by 103
Bull, H. A., Brickell, P. M., & Dowd, P. M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00814-0 · Cited by 102
Leung, L. L. K., Li, W. X., McGregor, J. L., et al. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37179-0 · Cited by 99
Disturbance of plasma and platelet thrombospondin levels in sickle cell disease
Browne, P., Mosher, D. F., Steinberg, M. H., & Hebbel, R. P. (1996) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199604)51:4<296::aid-ajh8>3.0.co;2-r · Cited by 97
Silverstein, R. L., Baird, M., Lo, S. K., & Yesner, L. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42046-7 · Cited by 96
Self-citationRecombinant GST/CD36 Fusion Proteins Define a Thrombospondin Binding Domain
Pearce, S. F. A., Wu, J., & Silverstein, R. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.2981 · Cited by 94
Self-citationDawes, J., Clemetson, K. J., Gogstad, G. O., McGregor, J. L., Clézardin, P., Prowse, C. V., & Pepper, D. S. (1983) · Thrombosis Research · doi:10.1016/0049-3848(83)90212-8 · Cited by 85
Assay and purification of naturally occurring inhibitor of angiogenesis
Polverini, P. J., Bouck, N., & Rastinejad, F. (1991) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(91)98044-7 · Cited by 70
Self-citationKieffer, N., Bettaı̈eb, A., Legrand, C., Coulombel, L., Vainchenker, W., Edelman, L., & BRETON-GORIUS, J. (1989) · Biochemical Journal · doi:10.1042/bj2620835 · Cited by 62
Li, W. X., Howard, R. J., & Leung, L. L. K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85403-0 · Cited by 60
RayChaudhury, A., Frazier, W. A., & D'Amore, P. A. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.1.39 · Cited by 52
Self-citationAn overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action
Gradishar, W. J. (1997) · Investigational New Drugs · doi:10.1023/a:1005770612294 · Cited by 46
Cited by
CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior
Silverstein, R. L., & Febbraio, M. (2009) · Science Signaling · doi:10.1126/scisignal.272re3 · Cited by 1,141
Self-citationSignals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
Jiménez, B., Volpert, O. V., Crawford, S. E., Febbraio, M., Silverstein, R. L., & Bouck, N. (2000) · Nature Medicine · doi:10.1038/71517 · Cited by 1,020
Self-citationMolecular Basis for the Regulation of Angiogenesis by Thrombospondin-1 and -2
Lawler, P. R., & Lawler, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006627 · Cited by 532
CD36, a scavenger receptor implicated in atherosclerosis
Park, Y. M. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.38 · Cited by 517
Peroxisome proliferator-activated receptors and hepatic stellate cell activation
Miyahara, T., Schrum, L., Rippe, R., Xiong, S., Yee, H. F., Motomura, K., Anania, F. A., Willson, T. M., & Tsukamoto, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006577200 · Cited by 473
Metadata
- Authors
- Dawson, D. W., Pearce, S. F. A., Zhong, R., Silverstein, R. L., Frazier, W. A., & Bouck, N. P.
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 1997-08-11
- Volume
- 138
- Issue
- 3
- Pages
- 707-717
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2055515174
- Cited by
- 676
- References
- 63
- FWCI
- 8.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.